ESPE2024 Poster Category 1 Pituitary, Neuroendocrinology and Puberty 2 (9 abstracts)
1Department of Pediatric Endocrinology, Faculty of Medicine, Ege University, Izmir, Turkey. 2Department of Child and Adolescent Psychiatry, Faculty of Medicine, Ege University, Izmir, Turkey
Introduction: Idiopathic central precocious puberty (CPP) is frequently associated with psychological issues.
Materials and Methods: The study comprised 21 cases with CPP and their parents, as well as 22 healthy controls and their parents. All participants underwent the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime (KSADS-PL) during psychiatric evaluation. Additionally, patients completed the Emotion Regulation Checklist (ERC), Revised Child Anxiety and Depression Scale –Child (RCADS-CV), and the Quality of Life (QOL) questionnaire. Parents completed the Attention Deficit Hyperactivity Disorder Scale (ADHD), Children Empathy-Systemize Scale (EQ-SQ), Strengths and Difficulties Questionnaire (SDQ), Revised Child Anxiety and Depression Scales-Parent Version (RCADS-P), Quality of Life (QOL) for their children, and the Beck Depression Inventory for themselves.
Results: The median age of the CPP and control groups was 7.6 years (range: 6 to 8years) and 7.2 years (range: 6.5 to 8 years), respectively. Based on the KSADS-PL assessment, only anxiety disorder was significantly higher in the CPP cases compared to the control group. Additionally, disparities were noted in various aspects, including impulsivity, physical and school functioning, peer and social problems, emotion regulation, and separation anxiety (Table 1).
25-75p | Median | SD | P | ||
RCADS-CV Social Phobia |
Case | 2,25-7,75 | 5,30 | 3,7 | 0,01 |
Control | 1-2 | 2,95 | 3 | ||
RCADS-CV Separation Anxiety |
Case | 2-8,75 | 6,05 | 4,7 | 0,00 |
Control | 1-4.2 | 3,55 | 3,5 | ||
RCADS-P Separation Anxiety |
Case | 4-8,7 | 6,6 | 4 | 0,05 |
Control | 1-3 | 3 | 3 | ||
SDQ Peer Problems |
Case | 3-5 | 4,4 | 1,2 | 0,03 |
Control | 1,7-5 | 3,1 | 1,9 | ||
SDQ Social Problems |
Case | 8-10 | 8,9 | 1,4 | 0,00 |
Control | 1,7-8 | 4,7 | 3,6 | ||
ERC Emotion Regulation Subscale |
Case | 11-25 | 16 | 3,2 | 0,04 |
Control | 7-20 | 14 | 4 | ||
ADHD Impulsivity Subscale |
Case | 2-6,7 | 4,2 | 2,8 | 0.04 |
Control | 0-3 | 2,5 | 4 | ||
QOL (child) Physical Functioning |
Case | 556-725 | 642 | 115 | 0,03 |
Control | 643-781 | 704 | 114 | ||
QOL (child) School Functioning |
Case | 225-500 | 380 | 83 | 0,05 |
Control | 368-500 | 428 | 75 | ||
QOL (parent) Physical Functioning |
Case | 518-743 | 606 | 172 | 0,02 |
Control | 687-775 | 689 | 142 | ||
QOL (parent) School Functioning |
Case | 406-475 | 431 | 58 | 0,05 |
Control | 425-500 | 455 | 60 |
Conclusion: Our findings suggest that patients diagnosed with precocious puberty are at an increased risk for psychiatric comorbidities compared to the control group. It is crucial to consider children's psychiatric comorbidities before initiating GnRH therapy. Additionally, this study provides data for future investigations aimed at assessing stress levels following GnRHa treatment.